| scholarly article | Q13442814 |
| P356 | DOI | 10.1182/BLOOD-2003-05-1597 |
| P698 | PubMed publication ID | 12855568 |
| P50 | author | Brenda M Sandmaier | Q75025355 |
| Hans Joachim Deeg | Q75039559 | ||
| Paul J Martin | Q85264853 | ||
| Takahiro Fukuda | Q88360274 | ||
| Katherine A Guthrie | Q91766748 | ||
| David K Madtes | Q114442001 | ||
| Rainer Storb | Q19546769 | ||
| David G. Maloney | Q27889042 | ||
| Michael Boeckh | Q56072917 | ||
| P2093 | author name string | Robert C Hackman | |
| Michael B Maris | |||
| P433 | issue | 8 | |
| P921 | main subject | pneumonia | Q12192 |
| Idiopathic pneumonia syndrome | Q5988895 | ||
| stem cell transplantation | Q65592366 | ||
| P304 | page(s) | 2777-2785 | |
| P577 | publication date | 2003-07-10 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | Risks and outcomes of idiopathic pneumonia syndrome after nonmyeloablative and conventional conditioning regimens for allogeneic hematopoietic stem cell transplantation | |
| P478 | volume | 102 |
| Q37276584 | A Critical Care and Transplantation-Based Approach to Acute Respiratory Failure after Hematopoietic Stem Cell Transplantation in Children. |
| Q39041930 | A call to arms: a critical need for interventions to limit pulmonary toxicity in the stem cell transplantation patient population |
| Q36665735 | A role for TNF receptor type II in leukocyte infiltration into the lung during experimental idiopathic pneumonia syndrome |
| Q42235831 | ACE deletion polymorphism is associated with a high risk of non-infectious pulmonary complications after stem cell transplantation |
| Q35858408 | Acute lung injury after allogeneic stem cell transplantation: is the lung a target of acute graft-versus-host disease? |
| Q35953264 | Allogeneic hematopoietic cell transplantation as treatment for hematological malignancies: a review |
| Q36310235 | Allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning as treatment for hematologic malignancies and inherited blood disorders |
| Q34145155 | Allogeneic hematopoietic cell transplantation: the state of the art |
| Q92600857 | Allogeneic reactivity-mediated endothelial cell complications after HSCT: a plea for consensual definitions |
| Q35694784 | An official American Thoracic Society research statement: noninfectious lung injury after hematopoietic stem cell transplantation: idiopathic pneumonia syndrome |
| Q40243803 | Blood transfusions and pulmonary complications after hematopoietic cell transplantation |
| Q37923305 | Bronchiolitis obliterans after allo-SCT: clinical criteria and treatment options. |
| Q46661653 | Comparison between reduced intensity and conventional myeloablative allogeneic stem-cell transplantation in patients with hematologic malignancies aged between 50 and 59 years |
| Q33420620 | Concurrent treatment with a tumor necrosis factor-alpha inhibitor and veno-venous extracorporeal membrane oxygenation in a post-hematopoietic stem cell transplant patient with idiopathic pneumonia syndrome: a case report |
| Q54253594 | Current Approach to Non-Infectious Pulmonary Complications of Hematopoietic Stem Cell Transplantation. |
| Q46638146 | Determination of acute lung injury after repeated platelet transfusions |
| Q47312420 | Diagnostic and Prognostic Plasma Biomarkers for Idiopathic Pneumonia Syndrome after Hematopoietic Cell Transplantation |
| Q81314412 | Dose intensity and the toxicity and efficacy of allogeneic hematopoietic cell transplantation |
| Q39287510 | Early Onset Noninfectious Pulmonary Syndromes after Hematopoietic Cell Transplantation |
| Q44579673 | Early pneumonia after allogenic stem cell transplantation |
| Q58725081 | Effect of dose rate on pulmonary toxicity in patients with hematolymphoid malignancies undergoing total body irradiation |
| Q36905597 | Epidemiology of Acute Respiratory Distress Syndrome Following Hematopoietic Stem Cell Transplantation |
| Q53642344 | Etanercept therapy for late-onset idiopathic pneumonia syndrome after nonmyeloablative allogeneic hematopoietic stem cell transplantation. |
| Q35750957 | Extended follow-up of methotrexate-free immunosuppression using sirolimus and tacrolimus in related and unrelated donor peripheral blood stem cell transplantation |
| Q58565569 | Fludarabine with a higher versus lower dose of myeloablative timed-sequential busulfan in older patients and patients with comorbidities: an open-label, non-stratified, randomised phase 2 trial |
| Q46774796 | Haematopoietic cell transplantation with non-myeloablative conditioning in Denmark: disease-specific outcome, complications and hospitalization requirements of the first 100 transplants. |
| Q44828700 | High-dose corticosteroids with or without etanercept for the treatment of idiopathic pneumonia syndrome after allo-SCT. |
| Q42072970 | Idiopathic pneumonia syndrome after bone marrow transplantation presenting with "crazy-paving" pattern on high-resolution computed tomography: a case report |
| Q35724040 | Idiopathic pneumonia syndrome after hematopoietic cell transplantation: evidence of occult infectious etiologies |
| Q79836232 | Incidence and outcome of idiopathic pneumonia syndrome in pediatric stem cell transplant recipients |
| Q90668424 | Incidence, Risk Factors, and Outcomes of Idiopathic Pneumonia Syndrome after Allogeneic Hematopoietic Cell Transplantation |
| Q80933894 | Increased frequency of the angiotensin-converting enzyme gene D-allele is associated with noninfectious pulmonary dysfunction following allogeneic stem cell transplant |
| Q36650481 | Influence of glutathione S-transferase gene polymorphisms on busulfan pharmacokinetics and outcome of hematopoietic stem-cell transplantation in thalassemia pediatric patients |
| Q33645826 | Influence of oral beclomethasone dipropionate on early non-infectious pulmonary outcomes after allogeneic hematopoietic cell transplantation: results from two randomized trials |
| Q83617223 | Late-onset non-infectious pulmonary complications following allogeneic hematopoietic stem cell transplantation in children |
| Q39855262 | Late-onset noninfectious interstitial lung disease following autologous haematopoietic stem cell transplantation in paediatric patients |
| Q35184667 | Long-term health impacts of hematopoietic stem cell transplantation inform recommendations for follow-up |
| Q35148420 | Low risk of chronic graft-versus-host disease and relapse associated with T cell-depleted peripheral blood stem cell transplantation for acute myelogenous leukemia in first remission: results of the blood and marrow transplant clinical trials networ |
| Q53547209 | Lower costs associated with hematopoietic cell transplantation using reduced intensity vs high-dose regimens for hematological malignancy. |
| Q81685802 | Lower incidence of Bronchiolitis obliterans in allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning compared with myeloablative conditioning |
| Q33712196 | Non-infectious pulmonary complications after the hematopoietic stem cell transplantation |
| Q47714833 | Noninfectious Acute Lung Injury Syndromes Early After Hematopoietic Stem Cell Transplantation |
| Q26748780 | Nonmyeloablative allogeneic hematopoietic cell transplantation |
| Q34962952 | Preventive usage of broad spectrum chemokine inhibitor NR58-3.14.3 reduces the severity of pulmonary and hepatic graft-versus-host disease. |
| Q80889996 | Prognostic value of serum surfactant protein D level prior to transplant for the development of bronchiolitis obliterans syndrome and idiopathic pneumonia syndrome following allogeneic hematopoietic stem cell transplantation |
| Q38447685 | Proteome Profiling in Lung Injury after Hematopoietic Stem Cell Transplantation |
| Q80213798 | Pulmonary complications after T-cell-depleted allogeneic stem cell transplantation: low incidence and strong association with acute graft-versus-host disease |
| Q36011668 | Pulmonary function testing prior to hematopoietic stem cell transplantation |
| Q34027424 | Randomized, double-blind, placebo-controlled trial of soluble tumor necrosis factor receptor: enbrel (etanercept) for the treatment of idiopathic pneumonia syndrome after allogeneic stem cell transplantation: blood and marrow transplant clinical tri |
| Q37405638 | Reduced incidence of interstitial pneumonitis after allogeneic hematopoietic stem cell transplantation using a modified technique of total body irradiation |
| Q35690761 | Reduced intensity conditioning for allogeneic hematopoietic cell transplantation: current perspectives |
| Q38366632 | Reduced-intensity conditioned allogeneic SCT in adults with AML. |
| Q36548370 | Reduced-intensity conditioning for acute myeloid leukemia: is this strategy correct |
| Q43610447 | Reduced-intensity stem-cell transplantation for adult acute lymphoblastic leukemia: a retrospective study of 33 patients |
| Q58121933 | Respiratory failure in the hematopoietic stem cell transplant recipient |
| Q45799176 | Risk factor analysis of idiopathic pneumonia syndrome after allogeneic hematopoietic SCT in children |
| Q35852267 | Rust and corrosion in hematopoietic stem cell transplantation: the problem of iron and oxidative stress |
| Q35672924 | Stable long-term pulmonary function after myeloablative double cord blood transplant. |
| Q89646878 | Standardized flattening filter free volumetric modulated arc therapy plans based on anteroposterior width for total body irradiation |
| Q34858453 | TNF-receptor inhibitor therapy for the treatment of children with idiopathic pneumonia syndrome. A joint Pediatric Blood and Marrow Transplant Consortium and Children's Oncology Group Study (ASCT0521). |
| Q92569958 | The Biological and Clinical Relevance of G Protein-Coupled Receptors to the Outcomes of Hematopoietic Stem Cell Transplantation: A Systematized Review |
| Q33760834 | The association between red blood cell and platelet transfusion and subsequently developing idiopathic pneumonia syndrome after hematopoietic stem cell transplantation |
| Q34607576 | The impact of soluble tumor necrosis factor receptor etanercept on the treatment of idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation |
| Q35903540 | The role of allogeneic transplantation in high-risk acute myelogenous leukemia |
| Q37342083 | The role of iron in patients after bone marrow transplantation |
| Q37796528 | The spectrum of noninfectious pulmonary complications following hematopoietic stem cell transplantation |
| Q40135885 | Vigorous inflammatory responses in noninfectious pulmonary complication induced by donor lymphocyte infusion |
Search more.